- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05425186
A Reliability and Validity Study: Urdu Version of Rivermead Extended Activities of Daily Life
June 15, 2022 updated by: Riphah International University
Analysis of Reliability and Validity of Urdu Version of Rivermead Extended Activities of Daily Life Among Pakistani Population
The goal of this study is to translate and culturally adapt Rivermead Extended Activities of Daily Life into the Urdu language and to evaluate its reliability and validity in the Pakistani neurological rehabilitation population.
Also assess its correlation with Memory and Concentration Test, The Barthel Index, and The index of French activities.
Study Overview
Status
Recruiting
Conditions
Detailed Description
As per the preceding commendation, Rivermead Extended Activities of Daily Life will be deciphered into the Urdu dialect from its English adaptation and adjusted socially in Pakistan.
Among the neurological rehabilitation population, Rivermead Extended Activities of Daily Life will be distributed in 100 patients enrolled by comfort inspecting strategy beneath the pre-defined incorporation and avoidance criteria after marking assent shapes.
For testing inter-observer unwavering quality and intra-observer unwavering quality of Rivermead Extended Activities of Daily Life, Memory and Concentration Test, index of French activities, and Barthel Index surveys will be managed by spectator, on the same day, with a time interval of 2 hours between 1st and 2nd readings.
As for the 3rd readings, it will be carried out after seven days by the first observer, for intra-observer appraisal.
Statistical Package of Social Sciences computer program has been utilized for information passage and examination.
Inner consistency will be analyzed with Cronbach alpha esteem.
Test-retest unwavering quality will be surveyed by utilizing an intra-class relationship coefficient.
The Rivermead Extended Activities of Daily Life will be assessed for content validity, construct validity, criterion validity, and responsiveness.
Study Type
Observational
Enrollment (Anticipated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Punjab
-
Faisalabad, Punjab, Pakistan, 38000
- Recruiting
- Ripah International university
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
We targeted the Pakistani stroke and head injury population received rehabilitation for neurological impairments in our study.
Description
Inclusion Criteria:
- Patients from Rehabilitation centers mainly outpatients; with more or severe impairments due to neurological /neuro-muscular diseases.
- Patient should be in a stable state unlikely to change over 2- weeks.
- Patient should score 18/28 short orientation-memory-concentration test; indicating a reasonable cognitive and communicative ability.
Exclusion Criteria:
- People not suffering from any neurological impairment.
- Scorning less than 18/28 on short orientation-memory-concentration test.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rivermead Extended Activities of Daily Life
Time Frame: 1st day
|
Rivermead Extended Activities of Daily Life having 10 things in it is in fact could be a complete independent community survival scale, covering all the fundamental independent living fashion needs.
Restoration administrations are pointed at accomplishing social autonomy within the community, on the off chance that conceivable, and must utilize an fitting degree of Rivermead Extended Activities of Daily Life when they are assessed themselves.
|
1st day
|
|
Memory and Concentration Test
Time Frame: 1st day
|
The Brief Introduction Memory and Concentration Test is one of numerous tests of memory and concentration.
It has the advantage of having decently culture-free substance.
In expansion, it covers moderately restricted zones of cognition: is the individual arranged; can the individual center on a brief errand; and can the person learn and keep in mind a number of basic things.
|
1st day
|
|
Frenchay Activities Index
Time Frame: 1st day
|
The Frenchay Activities Index is a measure of instrumental activities of daily living for use with patients recovering from stroke.
|
1st day
|
|
Barthel Index
Time Frame: 1st day
|
The Barthel index is used to assess disability and to monitor changes in disability over time.
The scoring method takes into account whether the person evaluated receives help while doing each task.
|
1st day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 30, 2021
Primary Completion (Anticipated)
July 10, 2022
Study Completion (Anticipated)
July 12, 2022
Study Registration Dates
First Submitted
June 15, 2022
First Submitted That Met QC Criteria
June 15, 2022
First Posted (Actual)
June 21, 2022
Study Record Updates
Last Update Posted (Actual)
June 21, 2022
Last Update Submitted That Met QC Criteria
June 15, 2022
Last Verified
June 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- REC-FSD-00263
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neurological Disorder
-
University of LeedsThe Royal College of Surgeons of EnglandCompletedSurgery | Surgery--Complications | Outcome, Fatal | Neurological Disorder | Morality | Neurological Morbidity | Neurological Complication | Comorbidities and Coexisting Conditions | Neurological Diseases or Conditions | Neurological Procedural Complication
-
Pôle Saint HélierINSA RennesCompleted
-
Pôle Saint HélierINSA RennesCompletedNeurological DisorderFrance
-
Collegium Medicum w BydgoszczyCompletedNeurological Complication of Procedure (Disorder)Poland
-
National Institute of Neurological Disorders and...CompletedNeurological DisorderUnited States
-
South West London and St George's Mental Health...CompletedFunctional Neurological Symptom DisorderUnited Kingdom
-
Forest Hills LabLiberyx Therapeutics Ltd.CompletedNeurological DisorderUnited States
-
University Hospital, ToulouseCompleted
-
University of Colorado, DenverRecruitingFunctional Neurological DisorderCanada
-
University Hospital, Basel, SwitzerlandRecruitingFunctional Neurological DisorderSwitzerland